VitaMedMD™ RediChew™ Rxchewable prenatal vitamin contains company's patented folate developed to further reduce impact of folic acid-related deficiencies.
TherapeuticsMD™ Inc., parent company of vitaMedMD® LLC, a specialty pharmaceutical company focused on therapies exclusively for women, today announced the recent launch of its third prescription prenatal vitamin, vitaMedMD™RediChew™ Rx.
The launch trails the introduction of vitaMedMD™ One Rx earlier this month and vitaMedMD™ Plus Rx last month, products similar to RediChew Rxin that they all contain the same combination of folic acid and the company's patented fourth-generation folate, Quatrefolic®.
Quatrefolic gives all three of the prenatal vitamins the potential to further reduce the impact of folic acid-related deficiencies.
Jason Spitz, vice president of marketing for TherapeuticsMD, detailed the originality of the new product.
"vitaMedMD RediChew Rx provides a great option for pregnant women who have difficulty swallowing tablets or capsules, or where nausea or morning sickness make taking tablets or capsules difficult. vitaMedMD RediChew Rx is also a suitable daily multivitamin choice for all women of childbearing age, as it provides the folic acid recommended by the U.S. Public Health Service, CDC, and the March of Dimes," Spitz stated in the press release. "With the addition of Quatrefolic, vitaMedMD prescription prenatals provide a 'body ready' form of folate, which is especially important for women with MTHFR polymorphisms who may not be able to fully metabolize synthetic folic acid. vitaMedMD RediChew Rx also contains vitamins B6 and B12, which may help relieve nausea and morning sickness."
TherapeuticsMD's prenatal vitamins are available by prescription at chain, independent, and mail order pharmacies throughout the United States.
For more information visit therapeuticsmd.com
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net